UK industry body says Sanofi in breach over RSV therapy claims against Pfizer - News Summed Up

UK industry body says Sanofi in breach over RSV therapy claims against Pfizer


AdvtJoin the community of 2M+ industry professionals. Subscribe to Newsletter to get latest insights & analysis in your inbox. Download the ETPharma App and get the Realtime updates and Save your favourite articles. "Sanofi remains committed to the highest standards of ethical conduct and responsible external engagement," the ​company added.Beyfortus is a preventive antibody, ​developed by Sanofi and AstraZeneca, to protect newborns from ‌a common respiratory ‍virus. (Reporting by Gnaneshwar Rajan in Bengaluru and Bhanvi Satija in London; Editing by Shinjini Ganguli)>


Source: Economic Times February 03, 2026 14:06 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */